Navegar

Colección

Datos Estadísticas

Lista de

VEGF
8
"Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome" (2014) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Journal of Steroid Biochemistry and Molecular Biology. 144(PART B):392-401
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells" (2010) Irusta, G.; Abramovich, D.; Parborell, F.; Tesone, M. Molecular and Cellular Endocrinology. 325(1-2):93-100
"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model" (2008) Quintana, R.;Kopcow, L.;Marconi, G. (...)Paz, D.A. Fertility and Sterility. 90(4 SUPPL):1511-1516